| 101 |
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00013 |
N.D.W.Va. |
|
|
|
|
| 102 |
Pfizer Inc. et al v. Mylan Pharmaceuticals Inc. |
1:15-cv-00013 |
N.D.W.Va. |
|
|
|
|
| 103 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
| 104 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
| 105 |
Baxter Healthcare Corporation et al v. Agila Specialties Private Limited et al |
1:14-cv-00190 |
N.D.W.Va. |
|
|
|
|
| 106 |
AbbVie Inc. v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-01236 |
D.Del. |
|
|
|
|
| 107 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
| 108 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
| 109 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
| 110 |
Boehringer Ingelheim Pharma Gmbh & Co. KG et al v. Mylan Pharmaceuticals Inc. |
1:14-cv-00146 |
N.D.W.Va. |
|
|
|
|
| 111 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
| 112 |
Acorda Therapeutics, Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:14-cv-00139 |
N.D.W.Va. |
|
|
|
|
| 113 |
OTSUKA PHARMACEUTICAL CO., LTD. v. MYLAN INC. et al |
1:14-cv-04508 |
D.N.J. |
|
|
|
|
| 114 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:14-cv-00099 |
N.D.W.Va. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
| 115 |
GILEAD SCIENCES, INC. et al v. Mylan Inc. et al |
1:14-cv-00099 |
N.D.W.Va. |
|
- 6 University/Government/Non-profit
- 8 Product company
|
|
|
| 116 |
AstraZeneca AB v. Mylan Pharmaceuticals Inc. |
1:14-cv-00094 |
N.D.W.Va. |
|
|
|
|
| 117 |
Gilead Sciences, Inc. et al v. Mylan Inc. et al |
1:14-cv-03928 |
S.D.N.Y. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 118 |
Gilead Sciences, Inc. et al v. Mylan Inc. et al |
1:14-cv-03928 |
S.D.N.Y. |
|
- 8 Product company
- 6 University/Government/Non-profit
|
|
|
| 119 |
WARNER CHILCOTT COMPANY, LLC v. MYLAN INC. et al |
3:13-cv-06560 |
D.N.J. |
|
|
|
|
| 120 |
Roche Palo Alto LLC et al v. Mylan Pharmaceuticals Inc. |
1:13-cv-01532 |
D.Del. |
|
|
|
|
| 121 |
Roche Palo Alto LLC et al v. Mylan Pharmaceuticals Inc. |
1:13-cv-01532 |
D.Del. |
|
|
|
|
| 122 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
| 123 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
| 124 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
| 125 |
UCB Inc. et al v. Mylan Pharmaceuticals Inc. et al |
1:13-cv-01214 |
D.Del. |
|
- 1 Acquired patents
- 8 Product company
|
|
|
| 126 |
Santarus Inc. et al v. Mylan Inc. et al |
1:13-cv-00145 |
D.Del. |
|
|
|
|
| 127 |
Santarus Inc. et al v. Mylan Inc. et al |
1:13-cv-00145 |
D.Del. |
|
|
|
|
| 128 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
| 129 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
| 130 |
JANSSEN PRODUCTS, L.P. et al v. LUPIN LIMITED et al |
2:12-cv-05358 |
D.N.J. |
|
|
|
|
| 131 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
| 132 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
| 133 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
| 134 |
Teva Pharmaceuticals USA, Inc. et al v. Synthon Pharmaceuticals, Inc. et al |
1:12-cv-02556 |
S.D.N.Y. |
|
- 2 University heritage or tie
- 8 Product company
|
|
|
| 135 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
| 136 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
| 137 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
| 138 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
| 139 |
Takeda Pharmaceutical Company Limited et al v. Mylan, Inc. et al |
1:12-cv-02038 |
S.D.N.Y. |
|
|
|
|
| 140 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
| 141 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
| 142 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
| 143 |
SHIRE LLC et al v. MYLAN PHARMACEUTICALS, INC. et al |
2:12-cv-00638 |
D.N.J. |
|
|
|
|
| 144 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 145 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 146 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 147 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 148 |
TAKEDA PHARMACEUTICAL COMPANY LIMITED et al v. MYLAN, INC. et al |
2:12-cv-00026 |
W.D.Pa. |
|
|
|
|
| 149 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|
| 150 |
ABBOTT LABORATORIES et al v. MYLAN PHARMACEUTICALS INC. et al |
2:11-cv-04966 |
D.N.J. |
|
|
|
|